Certara Scientists are Among the Topmost Cited Biopharma Researchers
Certara, Inc. (CERT)
Company Research
Source: GlobeNewswire
RADNOR, Pa., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced its continued influence in pharmaceutical research. With more than 200 papers authored by Certara scientists* this past year and 11 Certara scientists included on the 2025 update of Stanford/Elsevier’s ranking of the top 2% most cited scientists across the globe, Certara’s powerhouse of scientific knowledge continues to drive innovation in drug discovery and development. Certara’s highly ranked experts reflect the company’s commitment to scientific insight and developing technological solutions that further patients’ access to new medicines. Now in its 8th iteration, the list includes the most-cited researchers globally in 22 scientific disciplines and 174 sub-disciplines and encompasses standardized data on citations, h-index, and a wide range of bibliometric indicators. “Rigorous and validated research that accelerates novel medicines d
Show less
Read more
Impact Snapshot
Event Time:
CERT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CERT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CERT alerts
High impacting Certara, Inc. news events
Weekly update
A roundup of the hottest topics
CERT
News
- Certara (NASDAQ:CERT) was upgraded by analysts at Rothschild Redb to a "strong-buy" rating.MarketBeat
- Certara (NASDAQ:CERT) was upgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=CERT&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> frMarketBeat
- Certara (NASDAQ:CERT) is now covered by analysts at Rothschild & Co Redburn. They set a "buy" rating and a $10.00 price target on the stock.MarketBeat
- Certara (NASDAQ:CERT) was given a new $10.00 price target on by analysts at Redburn Partners.MarketBeat
- Certara (NASDAQ:CERT) had its "sell (d+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
CERT
Earnings
- 11/6/25 - Beat
CERT
Sec Filings
- 11/25/25 - Form SCHEDULE
- 11/12/25 - Form 4
- 11/6/25 - Form 10-Q
- CERT's page on the SEC website